China And US Added to Amneal-Iconovo Symbicort Alliance

Expands Agreement Disclosed In May Last Year

Swedish player Iconovo is in line for larger future royalties through its partnership with Amneal covering a generic version of AstraZeneca’s Symbicort, after the two firms signed a new, expanded agreement.

Business teamwork puzzle pieces.
Amneal and Iconovo first joined forces in June 2016 • Source: Shutterstock

More from Deals

More from Business